Literature DB >> 33481812

A novel score system of blood tests for differentiating Kawasaki disease from febrile children.

Chih-Min Tsai1, Chi-Hsiang Chu2, Xi Liu3, Ken-Pen Weng4,5, Shih-Feng Liu6,7, Ying-Hsien Huang1,8, Ho-Chang Kuo1,6,8.   

Abstract

BACKGROUND: Kawasaki disease is the most common cause of acquired heart disease among febrile children under the age of 5 years old. It is also a clinically diagnosed disease. In this study, we developed and assessed a novel score system using objective parameters to differentiate Kawasaki disease from febrile children.
METHODS: We analyzed 6,310 febrile children and 485 Kawasaki disease subjects in this study. We collected biological parameters of a routine blood test, including complete blood count with differential, C-reactive protein, aspartate aminotransferase, and alanine aminotransferase. Receiver operating characteristic curve, logistic regression, and Youden's index were all used to develop the prediction model. Two other independent cohorts from different hospitals were used for verification.
RESULTS: We obtained eight independent predictors (platelets, eosinophil, alanine aminotransferase, C-reactive protein, hemoglobin, mean corpuscular hemoglobin, mean corpuscular hemoglobin concentration, and monocyte) and found the top three scores to be eosinophil >1.5% (score: 7), alanine aminotransferase >30 U/L (score: 6), and C-reactive protein>25 mg/L (score: 6). A score of 14 represents the best sensitivity value plus specificity prediction rate for Kawasaki disease. The sensitivity, specificity, and accuracy for our cohort were 0.824, 0.839, and 0.838, respectively. The verification test of two independent cohorts of Kawasaki disease patients (N = 103 and 170) from two different institutes had a sensitivity of 0.780 (213/273).
CONCLUSION: Our findings demonstrate a novel score system with good discriminatory ability for differentiating between children with Kawasaki disease and other febrile children, as well as highlight the importance of eosinophil in Kawasaki disease. Using this novel score system can help first-line physicians diagnose and then treat Kawasaki disease early.

Entities:  

Year:  2021        PMID: 33481812      PMCID: PMC7822339          DOI: 10.1371/journal.pone.0244721

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


  44 in total

Review 1.  State-of-the-art acute phase management of Kawasaki disease after 2017 scientific statement from the American Heart Association.

Authors:  Yi-Ching Liu; Ming-Tai Lin; Jou-Kou Wang; Mei-Hwan Wu
Journal:  Pediatr Neonatol       Date:  2018-03-30       Impact factor: 2.083

2.  Evolution of laboratory values in patients with Kawasaki disease.

Authors:  Adriana H Tremoulet; Sonia Jain; Divya Chandrasekar; Xiaoying Sun; Yuichiro Sato; Jane C Burns
Journal:  Pediatr Infect Dis J       Date:  2011-12       Impact factor: 2.129

3.  A new infantile acute febrile mucocutaneous lymph node syndrome (MLNS) prevailing in Japan.

Authors:  T Kawasaki; F Kosaki; S Okawa; I Shigematsu; H Yanagawa
Journal:  Pediatrics       Date:  1974-09       Impact factor: 7.124

4.  Early Differentiation of Kawasaki Disease Shock Syndrome and Toxic Shock Syndrome in a Pediatric Intensive Care Unit.

Authors:  Ying-Jui Lin; Ming-Chou Cheng; Mao-Hung Lo; Shao-Ju Chien
Journal:  Pediatr Infect Dis J       Date:  2015-11       Impact factor: 2.129

5.  Coronary artery fistula associated with Kawasaki disease.

Authors:  Chi-Di Liang; Ho-Chang Kuo; Kuender D Yang; Chih-Lu Wang; Sheung-Fat Ko
Journal:  Am Heart J       Date:  2009-02-03       Impact factor: 4.749

6.  Persistent monocytosis after intravenous immunoglobulin therapy correlated with the development of coronary artery lesions in patients with Kawasaki disease.

Authors:  Ho Chang Kuo; Chih Lu Wang; Chi Di Liang; Hong Ren Yu; Hsin Hsu Chen; Lin Wang; Kuender D Yang
Journal:  J Microbiol Immunol Infect       Date:  2007-10       Impact factor: 4.399

7.  The prevention of coronary artery aneurysm in Kawasaki disease: a meta-analysis on the efficacy of aspirin and immunoglobulin treatment.

Authors:  K Durongpisitkul; V J Gururaj; J M Park; C F Martin
Journal:  Pediatrics       Date:  1995-12       Impact factor: 7.124

8.  Significance of Differential Characteristics in Infantile Kawasaki Disease.

Authors:  Ji Hee Kwak; JungHwa Lee; Kee Soo Ha
Journal:  Korean Circ J       Date:  2019-04-05       Impact factor: 3.243

9.  Comparison of the laboratory data between Kawasaki disease and enterovirus after intravenous immunoglobulin treatment.

Authors:  Li-Yan Lin; Tsung-Hsien Yang; Ying-Jui Lin; Hong-Ren Yu; Kuender D Yang; Yi-Chuan Huang; Wei-Chiao Chang; Ho-Chang Kuo
Journal:  Pediatr Cardiol       Date:  2012-03-25       Impact factor: 1.655

10.  Meta-analysis of factors predicting resistance to intravenous immunoglobulin treatment in patients with Kawasaki disease.

Authors:  Jin-Young Baek; Min Seob Song
Journal:  Korean J Pediatr       Date:  2016-02-29
View more
  3 in total

1.  An Artificial Intelligence-guided signature reveals the shared host immune response in MIS-C and Kawasaki disease.

Authors:  Pradipta Ghosh; Gajanan D Katkar; Chisato Shimizu; Jihoon Kim; Soni Khandelwal; Adriana H Tremoulet; John T Kanegaye; Joseph Bocchini; Soumita Das; Jane C Burns; Debashis Sahoo
Journal:  Nat Commun       Date:  2022-05-16       Impact factor: 17.694

2.  Combination of Hemoglobin-for-Age Z-Score and Plasma Hepcidin Identified as a Novel Predictor for Kawasaki Disease.

Authors:  Ya-Ling Yang; Ho-Chang Kuo; Kuang-Den Chen; Chi-Hsiang Chu; Kuang-Che Kuo; Mindy Ming-Huey Guo; Ling-Sai Chang; Ying-Hsien Huang
Journal:  Children (Basel)       Date:  2022-06-18

3.  Expression of Eosinophilic Subtype Markers in Patients with Kawasaki Disease.

Authors:  Ling-Sai Chang; Kuang-Den Chen; Ying-Hsien Huang; Ho-Chang Kuo
Journal:  Int J Mol Sci       Date:  2022-09-03       Impact factor: 6.208

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.